tiprankstipranks
Cormedix (CRMD)
NASDAQ:CRMD
Holding CRMD?
Track your performance easily

Cormedix (CRMD) Technical Analysis

1,229 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
6Neutral
10Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Cormedix’s (CRMD) Moving Averages Convergence Divergence (MACD) indicator is -0.50, suggesting Cormedix is a Buy.
Cormedix’s (CRMD) 20-Day exponential moving average is 9.23, while Cormedix’s (CRMD) share price is $8.57, making it a Sell.
Cormedix’s (CRMD) 50-Day exponential moving average is 9.44, while Cormedix’s (CRMD) share price is $8.57, making it a Sell.

Cormedix (CRMD) Pivot Points

Dec 22, 2024, 06:30 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
7.70
8.00
8.43
8.73
9.16
9.46
9.89
Fibonacci
8.00
8.28
8.45
8.73
9.01
9.18
9.46
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cormedix (CRMD) Moving Averages

Dec 22, 2024, 06:30 AM
Period
Simple
Exponential
MA5
8.48Buy
8.60Sell
MA10
8.76Sell
8.80Sell
MA20
9.29Sell
9.23Sell
MA50
10.35Sell
9.44Sell
MA100
8.35Buy
8.58Sell
MA200
6.57Buy
6.95Buy
Cormedix’s (CRMD) 10-Day exponential moving average is 8.80, while Cormedix’s (CRMD) share price is $8.57, making it a Sell.
Cormedix’s (CRMD) 100-Day exponential moving average is 8.58, while Cormedix’s (CRMD) share price is $8.57, making it a Sell.
Cormedix’s (CRMD) stock price is $8.57 and Cormedix’s (CRMD) 50-day simple moving average is 10.35, creating a Sell signal.
Cormedix’s (CRMD) stock price is $8.57 and Cormedix’s (CRMD) 100-day simple moving average is 8.35, creating a Buy signal.
Cormedix’s (CRMD) stock price is $8.57 and Cormedix’s (CRMD) 200-day simple moving average is 6.57, creating a Buy signal.

Cormedix (CRMD) Technical Indicators

Dec 22, 2024, 06:30 AM
Name
Value
Implied Action
RSI (14)
40.01
Neutral
STOCH (9,6)
31.99
Neutral
STOCHRSI (14)
25.33
Neutral
MACD (12,26)
-0.50
Buy
ADX (14)
26.00
Neutral
Williams %R
-71.27
Buy
CCI (14)
-80.52
Neutral
ATR (14)
0.59
-
Ultimate Oscillator
38.96
Neutral
ROC
-13.43
Sell
Cormedix’s (CRMD) Relative Strength Index (RSI) is 40.01, creating a Neutral signal.
Cormedix’s (CRMD) Trend Strength Indicator (ADX) is 26.00, creating a Neutral signal.
Cormedix’s (CRMD) Commodity Channel Index (CCI) is -80.52, creating a Neutral signal.
Cormedix’s (CRMD) Price Rate of Change (ROC) is -13.43, creating a Sell signal.

FAQ

Is CRMD a Buy, Hold, or Sell?
Based on CRMD’s technical indicators, CRMD is a Sell.
    What is CRMD’s RSI (14)?
    CRMD’s RSI (14) is 40.01, which suggests CRMD is a Neutral.
      What is CRMD’s MACD?
      CRMD’s MACD is -0.50, which suggests CRMD is a Buy.
        What is CRMD’s 5-day moving average?
        CRMD’s 5-day moving average is 8.48, which suggests CRMD is a Buy.
          What is CRMD’s 20-day moving average?
          CRMD 20-day moving average is 9.29, which suggests CRMD is a Sell.
            What is CRMD’s 50-day moving average?
            CRMD’s 50-day moving average is 10.35, which suggests CRMD is a Sell.
              What is CRMD’s 200-day moving average?
              CRMD’s 200-day moving average is 6.57, which suggests CRMD is a Buy.
                What is CRMD’s Williams % R (14)?
                CRMD’s Williams % R (14) is -71.27, which suggests CRMD is a Buy.
                  What is CRMD’s CCI (14)?
                  CRMD’s CCI (14) is -80.52, which suggests CRMD is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis